{
  "ptid_time": "127_S_0925_2009-11-04",
  "img_path": "/data/qiuhui/data/adni/images/127_S_0925/2009-11-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 76,483 mm³, 98.6% above the reference mean. With a Z-score of 2.36 (99.1th percentile), this represents significant enlargement; whole brain volume measures 989,491 mm³, 8.3% below the reference mean. With a Z-score of -1.08 (14.0th percentile), this represents mild atrophy. ",
  "text_data": "Age is 77.4 years. Gender is Male. Education: 12 years. MMSE: 24.0. Logical Memory: 7.0. APOEε4 alleles: 0.0. Biomarker levels: Pittsburgh compound B: 1.60 SUVR (normal ); Amyloid beta: 442.90 pg/mL (moderate reduced); Total tau: 140.10 pg/mL (mild reduced); Phosphorylated tau: 12.95 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (98.6% above mean) and mild whole brain atrophy (8.3% below mean), consistent with neurodegenerative changes. The MMSE score of 24 suggests mild cognitive impairment, while the moderate reduction in Aβ (amyloid-beta) and mild reductions in tau biomarkers suggest possible Alzheimer's pathology, though the APOE4-negative status and reduced tau levels complicate the picture.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology, but not definitive dementia yet).  \n\n**Confidence:** **Medium** (due to mixed biomarker findings and lack of clear clinical dementia symptoms).",
  "timestamp": "2025-07-26T13:04:28.699221"
}